Stock Events

Stock Events

Staar Surgical 

€23.07
48
+€1.16+5.27% Monday 06:03

Statistics

Day High
23.07
Day Low
23.07
52W High
24.46
52W Low
13.64
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q4 2025
Next
-0.17
-0.06
0.05
0.15
Expected EPS
0.02384200982
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SR3.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson's vision care division competes directly with Staar Surgical in the eye health market, particularly in products related to cataract and refractive surgery.
Alcon
ALC
Mkt Cap37.03B
Alcon specializes in eye care products, including surgical devices and equipment for cataract and refractive surgery, directly competing with Staar Surgical's product offerings.
Cooper Companies
COO
Mkt Cap12.17B
The Cooper Companies operate through CooperVision, which competes in the contact lens market, and CooperSurgical, which, while more focused on women's health, has overlaps in surgical products that can compete with Staar's offerings.
Bausch Health Companies
BHC
Mkt Cap2.11B
Bausch Health Companies, through its division Bausch + Lomb, competes in the eye health sector, offering products that range from contact lenses to surgical devices, overlapping with Staar Surgical's market.
Novartis
NVS
Mkt Cap279.67B
Novartis, through its Alcon eye care division before its spin-off, was a direct competitor, and continues to have interests in the healthcare sector that indirectly compete with Staar Surgical's eye surgery products.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, after acquiring Allergan, competes in the eye care market, particularly with products for eye health and surgery, which can be seen as indirect competition to Staar Surgical's offerings.
Eco Science Solutions
ESSI
Mkt Cap26,479
EyeSys Technologies is a smaller player but competes in the corneal topography market, which is relevant for pre-surgical assessments in procedures that Staar Surgical's products are used for.

About

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Show more...
CEO
Mr. Warren Foust
Employees
921
Country
United States
ISIN
US8523123052

Listings

MU
DE
SR3.MU
STU
DE
SR3.STU
F
DE
SR3.F
XNAS
US
STAA

0 Comments

Share your thoughts

FAQ

What is Staar Surgical stock price today?▼
The current price of SR3.MU is €23.07 EUR — it has increased by +5.27% in the past 24 hours. Watch Staar Surgical stock price performance more closely on the chart.
What is Staar Surgical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Staar Surgical stocks are traded under the ticker SR3.MU.
Is Staar Surgical stock price growing?▼
SR3.MU stock has risen by +1.7% compared to the previous week, the month change is a +40.62% rise, over the last year Staar Surgical has showed a +38.14% increase.
When is the next Staar Surgical earnings date?▼
Staar Surgical is going to release the next earnings report on May 13, 2026.
What were Staar Surgical earnings last quarter?▼
SR3.MU earnings for the last quarter are -0.17 EUR per share, whereas the estimation was 0.15 EUR resulting in a -211.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Staar Surgical have?▼
As of May 06, 2026, the company has 921 employees.
In which sector is Staar Surgical located?▼
Staar Surgical operates in the Health & Wellness sector.
When did Staar Surgical complete a stock split?▼
Staar Surgical has not had any recent stock splits.
Where is Staar Surgical headquartered?▼
Staar Surgical is headquartered in Lake Forest, United States.